Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dexamfetamina
Dexamfetamine
(+)-¦Á-methylphenethylamine
Dextroamphetamine
Dexamfetaminum
d-amphetamine
(+)-amphetamine
Dexanfetamina
Dexamphetamine
(S)-amphetamine
Dextroamphetamine sulfate
(¦ÁS)-¦Á-methylbenzeneethanamine
Dextroamphetamine saccharate
(S)-(+)-¦Â-phenylisopropylamine
(+)-(S)-amphetamine
(S)-(+)-amphetamine
Desamfetamina
Dextroamphetamine adipate
(S)-1-phenyl-2-propylamine
(+)-¦Á-methylphenylethylamine
(S)-1-phenyl-2-aminopropane
(S)-¦Á-methylbenzeneethanamine
Brand Names
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682